Puma Biotechnology, Inc.
PBYI
$3.00
-$0.01-0.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.31M | 20.32M | -4.53M | -4.82M | 12.27M |
| Total Depreciation and Amortization | 2.84M | 2.88M | 2.91M | 2.90M | 2.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.35M | 2.01M | 1.88M | 2.49M | 2.80M |
| Change in Net Operating Assets | -7.89M | -14.16M | 769.00K | 10.68M | -7.50M |
| Cash from Operations | 15.61M | 11.04M | 1.03M | 11.25M | 10.46M |
| Capital Expenditure | -16.00K | -20.00K | -20.00K | -- | -45.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.30M | 279.00K | 723.00K | -19.08M | -8.13M |
| Cash from Investing | -2.32M | 259.00K | 703.00K | -19.08M | -8.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.11M | -11.11M | -11.11M | -- | -- |
| Issuance of Common Stock | 0.00 | 150.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -221.00K | -223.00K | -222.00K | -- | -- |
| Cash from Financing | -11.33M | -11.18M | -11.33M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.96M | 114.00K | -9.60M | -7.83M | 2.29M |